Patrick Bryant
@Patrick18287926
Followers
2K
Following
562
Media
34
Statuses
451
Dedicated scientist.
Stockholm, Sweden
Joined November 2020
The future of drug design is in AI. Let me introduce our new work, RareFoldGPCR: Agonist Design Beyond Natural Amino Acids. Paper: https://t.co/Xd5UMDI4IF Code: https://t.co/N4JuxIl6o5
3
33
167
This is a rare trait among humans - chimps are probably more rational
The ability to change your mind in response to better evidence is a hallmark of human cognition. Experiments now show that chimps are capable of rational thought too https://t.co/U9v5ZdjBg6
0
0
1
The secret to the naked mole-rats’ extraordinarily long life may lie in subtle changes to just four amino acids, researchers report in Science. https://t.co/KtzxnmH3nX
10
50
187
We need to stop scaling with waste. RareFold proves that cutting-edge therapeutic design can and must go hand-in-hand with computational efficiency. Try the new, efficient implementation of RareFold here:
github.com
Structure prediction and design of proteins with noncanonical amino acids - patrickbryant1/RareFold
0
0
2
We tackled the silent killer: GPU Waste in protein design. The old way: 25 separate GPUs for a multi-length design campaign. The RareFold way: 1 single GPU handles the entire 25× workload! That’s a 25× reduction in peak hardware demand. 🤯
1
0
8
Check out the pretty logo my great student Diandra Daumiller made for our software EvoBind! It is already quite popular, but I suspect this will make it even more so. (logo description: EvoBind, EB, as a cyclic peptide)
1
0
2
There is also a short video here:
docs.google.com
RareFoldGPCR
The future of drug design is in AI. Let me introduce our new work, RareFoldGPCR: Agonist Design Beyond Natural Amino Acids. Paper: https://t.co/Xd5UMDI4IF Code: https://t.co/N4JuxIl6o5
0
4
14
🔹 Key advances: • Supports non-canonical AAs • Designs linear & cyclic peptide agonists • Validated GLP1R activation • Enables pathway-specific (biased) agonism
0
0
0
Thanks! Expanded chemistry means more possible drugs, hopefully it can help with many diseases
0
0
1
Excited to share our new work on the future of functional drug design. RareFoldGPCR: Agonist Design Beyond Natural Amino Acids.
0
1
4
Three days left to apply! Come work with us and change the world with peptide design!
su.varbi.com
The Department of Molecular Biosciences, Wenner-Gren Institute (MBW) conducts experimental basic research in molecular cell biology, integrative biology and infection and immune biology. The research
0
3
4
A reminder that there is now *1 week* left until the MLSB deadline on October 1st! Send in your 🧪bio+🤖ML papers, for either 🇺🇸San Diego, 🇩🇰Copenhagen, or ✨both✨!
🚨To accommodate the addition of EuroMLSB, we have extended the submission deadline to October 1, 2025 11:59pm AoE. Find information on paper guidelines at https://t.co/wv9C4wezso. Submissions will be made through CMT.
0
7
46
Thrilled to announce that the first paper from Flemmings PhD was accepted as Poster for NeurIPS2025! In this paper we adapt the HollowNet idea from @RickyTQChen to equivariant MP networks, to get cheap sample likelihoods for CNF-based Boltzmann Generators. Preprint/code soon.
0
4
22
Excited to share an important advance in AI and math. Together with mathematicians from @BrownUniversity, @nyuniversity and @Stanford, we developed a new AI-powered method that has discovered an entirely new family of solutions to several complex equations in fluid dynamics.
14
113
1K
We’re hiring a Postdoc in protein design! 📍 2-year position in Stockholm Join us to shape the future of drug design! Work on wet lab validation (cells, affinity) & expand your AI skills.
1
0
1
If you are like us and want to improve the world and have a real impact, apply here: https://t.co/HTHUgihojm More about my lab: https://t.co/iS5NDvy6Xl Email me at patrick.bryant@scilifelab.se if you have any questions.
patrickbryantlab.github.io
We build the technology of the future.
0
0
0
In the past year, we have: 1. Designed dual GLP1R/GCGR agonists: https://t.co/7FcMTlsjEO 2. HIV inhibitors: https://t.co/4rFCrHvGPm 3. Pioneered structure prediction and design with noncanonical amino acids:
biorxiv.org
Protein structure prediction and design have traditionally been limited to the 20 canonical amino acids. Expanding this space to include noncanonical amino acids (NCAAs) offers new opportunities for...
0
0
0